Benzinga | Nov 9, 2020 04:20PM EST

ChemoCentryx Q3 EPS $(0.35) Misses $(0.31) Estimate, Sales $5.08M Miss $10.70M Estimate

ChemoCentryx (NASDAQ:CCXI) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.31) by 12.9 percent. This is a 59.09 percent decrease over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $5.08 million which missed the analyst consensus estimate of $10.70 million by 52.48 percent. This is a 51.94 percent decrease over sales of $10.58 million the same period last year.